Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLOD2 | O00469 | 5/20 | 1.00 |
| ▸ | PLOD3 | O60568 | 3/20 | 1.00 |
| ▸ | PLOD1 | Q02809 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5805684 | 0.98 | PLOD2 (0.96) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL10948430 | 0.81 | PLOD2 (0.83) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL313164 | 0.81 | PLOD2 (0.70) | PLOD2PLOD3PLOD1ALDH1A1PTPN1 | |
| SCHEMBL21408730 | 0.80 | PLOD2 (0.67) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL523476 | 0.80 | PLOD2 (0.69) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL1925385 | 0.79 | PLOD2 (1.00) | PLOD2PLOD3PLOD1ALDH1A1HIF1A | |
| SCHEMBL711849 | 0.78 | PLOD2 (1.00) | PLOD2PLOD3PLOD1HPGDKDM4E | |
| SCHEMBL9654173 | 0.78 | PLOD2 (0.67) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL10613054 | 0.78 | PLOD2 (0.67) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 | |
| SCHEMBL9630807 | 0.78 | PLOD2 (0.67) | PLOD2PLOD3PLOD1ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161869-B | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119161869-A | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2024-12-20 | — | — | CN | claimed |
| CN-121108160-A | Down-conversion luminescent material based on pyridyl beta-diketone rare earth complex, and preparation method and application thereof | 宁夏医科大学 | 2025-12-12 | — | — | CN | disclosed |
| CN-119161869-B | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-119161869-B | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2025-06-24 | — | — | CN | disclosed |
| WO-2025049419-A1 | PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS | GENZYME CORPORATION (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-119161869-A | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2024-12-20 | — | — | CN | disclosed |
| CN-119161869-A | Rare earth europium metal complex stress luminescent material and preparation method and application thereof | 宁夏大学 | 2024-12-20 | — | — | CN | disclosed |
| WO-2024215863-A2 | INHIBITING MONOACYLGLYCEROL LIPASE (MAGL) | PSY THERAPEUTICS, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| EP-1670801-B1 | PYRAZOLO AND IMIDAZO-PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2011-06-08 | — | — | EP | disclosed |
| US-7790725-B2 | Thiazolidine derivatives and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-09-07 | — | — | US | disclosed |
| US-20050130992-A1 | Pyrazolo-pyridine | F. HOFFMANN-LA ROCHE AG (CH) | 2005-06-16 | — | — | US | disclosed |
| WO-2005040171-A1 | PYRAZOLO AND IMIDAZO-PYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-05-06 | — | — | WO | disclosed |
| EP-1495005-A1 | PYRAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | Pfizer Japan Inc. (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-20040259883-A1 | Thiazolidine derivative and medicinal use thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1426366-A1 | THIAZOLIDINE DERIVATIVE AND MEDICINAL USE THEREOF | Mitsubishi Pharma Corporation (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-20040019045-A1 | 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents | HIRANO MISATO (JP) | 2004-01-29 | — | — | US | disclosed |
| WO-2003087061-A1 | PYRAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER JAPAN INC. (JP) | 2003-10-23 | — | — | WO | disclosed |
| US-4582833-A | HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
| US-4576943-A | NERVOUS SYSTEM DISORDERS, SEDATIVES, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019045-A1 | 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents | PTGER1, PTGS1, PTGIR | PLOD2 3220/4885PLOD3 3597/4885PLOD1 2898/4885 |
| US-20050130992-A1 | Pyrazolo-pyridine | CHRM2, CHRM1, QDPR | PLOD2 3738/4885PLOD3 3474/4885PLOD1 3848/4885 |
| US-20040259883-A1 | Thiazolidine derivative and medicinal use thereof | DPP4, DPP7, DPP3 | PLOD2 4023/4885PLOD3 2487/4885PLOD1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.